OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistance
Ting Jiang, Xisha Chen, Xingcong Ren, et al.
Drug Resistance Updates (2021) Vol. 56, pp. 100752-100752
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Anticancer drug resistance: An update and perspective
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Drug Resistance Updates (2021) Vol. 59, pp. 100796-100796
Open Access | Times Cited: 248

New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects
Maohua Huang, Yuning Lin, Chenran Wang, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100849-100849
Closed Access | Times Cited: 96

Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents
Enrique Domínguez‐Álvarez, Bálint Rácz, Małgorzata Anna Marć, et al.
Drug Resistance Updates (2022) Vol. 63, pp. 100844-100844
Open Access | Times Cited: 70

Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy
Qiaolin Liu, Yuliang Zhao, Huige Zhou, et al.
Regenerative Biomaterials (2023) Vol. 10
Open Access | Times Cited: 37

Microneedle-assisted vaccination combined with autophagy regulation for antitumor immunotherapy
Dan Yang, Minglong Chen, Ying Sun, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 641-654
Closed Access | Times Cited: 26

Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition
Sunanda Singh, Héctor W. Gómez, Shreya Thakkar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4722-4722
Open Access | Times Cited: 23

The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications
Yu Ma, Ting Wang, Xudong Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 13

NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1
Zhiheng Zhang, Bojiao Song, Haowei Wei, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101040-101040
Closed Access | Times Cited: 11

Targeting autophagy overcomes cancer‐intrinsic resistance to CAR‐T immunotherapy in B‐cell malignancies
Lu Tang, Huan Zhang, Fen Zhou, et al.
Cancer Communications (2024) Vol. 44, Iss. 3, pp. 408-432
Open Access | Times Cited: 9

Impact of endoplasmic reticulum aminopeptidases 1 (ERAP1) and 2 (ERAP2) on neutrophil cellular functions
Irma Saulle, Fiona Limanaqi, Micaela Garziano, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1

Autophagy inhibition recovers deficient ICD-based cancer immunotherapy
Jinbo Li, Wenxu Cai, Jiang Yu, et al.
Biomaterials (2022) Vol. 287, pp. 121651-121651
Closed Access | Times Cited: 33

New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways
Alma Martelli, Marzieh Omrani, Maryam Zarghooni, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5839-5839
Open Access | Times Cited: 33

Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy
Sihui Yu, Hongyang Xiao, Li Ma, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188946-188946
Closed Access | Times Cited: 19

Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy
Jing Liang, Xiaohui Qiao, Luping Qiu, et al.
Advanced Science (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 19

Biological effects of metal-based nanomaterials for tumor metalloimmunotherapy
Huali Lei, Guanghui Hou, Minjiang Chen, et al.
Nano Today (2023) Vol. 53, pp. 102033-102033
Closed Access | Times Cited: 17

Activation of autophagy by in situ Zn2+ chelation reaction for enhanced tumor chemoimmunotherapy
Yang Yang, Yefei Zhu, Kairuo Wang, et al.
Bioactive Materials (2023) Vol. 29, pp. 116-131
Open Access | Times Cited: 16

Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 7

Understanding the Role of Autophagy in Cancer Formation and Progression Is a Real Opportunity to Treat and Cure Human Cancers
Simone Patergnani, Sonia Missiroli, Giampaolo Morciano, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5622-5622
Open Access | Times Cited: 39

Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy
Zhicheng Jin, Xuefeng Sun, Yaoyao Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20

Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1
Hongpei Tan, Jiahao Liu, Jing Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 11

Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer
Yue Wang, Dhamotharan Pattarayan, Haozhe Huang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4

The effects of autophagy-modifying drugs chloroquine and lithium on the skin melanoma microenvironment
Iuliia Taskaeva, Anastasia Shatruk, Igor Ivanov, et al.
Tissue and Cell (2025) Vol. 93, pp. 102753-102753
Closed Access

Pan-Cancer Analysis Identifies YKT6 as a Prognostic and Immunotherapy Biomarker, with an Emphasis on Cervical Cancer
Jiamin Liu, Qiang Zhang, Ling He, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 107-127
Open Access

Page 1 - Next Page

Scroll to top